European Parliament: Greek pharmacists requested measures to avoid drug shortages
Greek pharmacists demanded serious measures to address drug shortages during an event at the European Parliament, placing blame on companies for not meeting their obligations.
Corona Vaccine Damage: Federal Court Helps Injured Patients
A German court ruled in favor of patients suffering from vaccine side effects, easing access to information from pharmaceutical companies regarding potential risks.
[Pharmaceutical and Bio News] SK Biopharm and Merck Healthcare Celebrate International Women’s Day
On March 8, various companies in the pharmaceutical and bio sectors celebrated International Women’s Day with events promoting diversity and inclusiveness.
First contract: PAHO offered national laboratories to sell medicines and supplies through regional funds
The Pan American Health Organization has opened opportunities for local pharmaceutical companies in Argentina to supply medicines and health products through regional funds, which is expected to lower costs and enhance technology transfer.
China biotech outlicensing tops US$52 billion in first 2 months after global deal surge
In the first two months of the year, China's biotech outlicensing has exceeded US$52 billion, driven by significant partnerships with multinational pharmaceutical companies.
The end of the best-selling prescription medication causes pain - 'Outrageous price'
The shortage of the widely-used anticoagulant apixaban in Finland has led to significant distress due to skyrocketing prices and limited access, caused by a patent dispute among pharmaceutical companies.
Hong Kong-listed Chinese drug firms set to turn corner on rising sales, licensing deals
Hong Kong-listed Chinese pharmaceutical companies are expected to experience profit growth driven by increased sales of innovative drugs and favorable licensing agreements despite existing pricing challenges.
[Healing and Companionship] Pharmaceutical Companies Join Forces to Raise Awareness on Rare Disease Day
On Rare Disease Day, various companies in South Korea united to raise awareness about the challenges faced by patients with rare diseases, coinciding with a reported increase in the number of new cases in the country.
Brazilian pharmaceutical companies seek Indian technology for weight loss pen manufacturing
Brazilian pharmaceutical firms Biomm and Amoveri are pursuing Indian technology agreements to produce weight loss pens ahead of the patent expiration for Ozempic in 2026.
Finland's most sold prescription medication ran out in pharmacies due to an unusual reason
A significant shortage of the widely used blood thinner apixaban has occurred in Finland's pharmacies due to a patent dispute among pharmaceutical companies, leaving only the original, more expensive version available.
Should pharmaceutical companies advertise to consumers?
The article discusses the personal experience of Tamar Abrams, who turned to Ozempic, a diabetes medication associated with weight loss, due to health issues stemming from personal hardships and the influence of advertising.
Pharmaceuticals say proposal to extend Ozempic patent pressures health spending
Pharmaceutical companies in Brazil criticize a proposal to extend the patent duration of medications, arguing it could increase healthcare costs and reduce access.
Mexico, on par with Great Britain and Europe in vaccine production: Moderna
Big pharmaceutical companies like Moderna are increasing investment in Mexico due to a measles outbreak that has claimed 31 lives and exceeded 10,000 cases.
Consequences of Job Cuts: Marburg Capitalists
Three pharmaceutical companies in Marburg are cutting hundreds of jobs, though it may not negatively impact the city's finances.
The fastest-growing pharmaceutical companies invest in innovation
Greece's rapidly growing pharmaceutical sector is investing heavily in innovation, driven by strategic mergers, acquisitions, and access to the U.S. market.
China charges former AstraZeneca executive – what it means for global pharmaceutical firms
China has formally charged former AstraZeneca executive Leon Wang with multiple offenses, highlighting pressures facing foreign pharmaceutical companies in a tightening regulatory environment.
Chinese investors pour into Hong Kong-listed drug stocks as international deals multiply
Chinese investors are increasingly investing in Hong Kong-listed pharmaceutical companies, influenced by rising international business collaborations.
Mexico signs agreement with laboratories to produce vaccines against Covid, dengue, and cancer
President Claudia Sheinbaum announced a partnership to produce mRNA vaccines in Mexico, involving the Health Secretary, Birmex, and pharmaceutical companies Liomont and Moderna.
Trump presents new website with discounts on medications
US President Donald Trump introduced a new website aimed at providing lower prices on prescription medications for American consumers, featuring agreements with major pharmaceutical companies.
White House unveils TrumpRx website for medication discounts
The White House launched TrumpRx.gov, a platform for consumers to access discounts on certain brand-name medications when paying cash, featuring 43 drugs from five pharmaceutical companies.
Trump presents TrumpRx: popular medications drop by up to 80% in new platform
President Donald Trump launched a website named TrumpRx that offers discounts on a range of medications, slashing prices by over 80% through agreements with pharmaceutical companies.
The Dynamics and Barriers in the Pharmaceutical Sector
The Greek pharmaceutical industry has announced investments and a stable framework for pharmaceutical policy from 2026 to 2030, while multinational companies seek governmental support for innovation and increased funding for pharmaceutical spending.
Trump struck deals with 16 drug companies. But they're still raising prices this year
Despite recent agreements with the Trump administration aimed at lowering drug prices, 16 major pharmaceutical companies have increased the list prices of some of their medications this January.
Closed meeting of Kimberly Guilfoyle with pharmaceutical companies at the Hellenic-American Chamber of Commerce
Kimberly Guilfoyle held a closed meeting with pharmaceutical companies at the Hellenic-American Chamber of Commerce to discuss key issues affecting the healthcare sector in Greece.
The US FDA requests the removal of the 'suicidal thoughts' warning from weight loss drugs
The FDA has requested pharmaceutical companies to remove warnings about potential suicidal thoughts from labels of common weight-loss medications, including Novo Nordisk's 'Wegovy' and Eli Lilly's 'Zyban', following a comprehensive review that found no link to such thoughts.
The public health system spends tens of millions of euros on unnecessarily high doses of cancer therapies
Spain's public health system incurs annual expenses of tens of millions of euros on excess doses of popular cancer immunotherapies, as pharmaceutical companies persuade regulatory bodies to standardize treatment based on inflated weight assumptions.
Meow or Never: China’s Pudgy Pets Spark Race for Weight-Loss Drugs
In China, the increasing obesity of pets is driving pharmaceutical companies to develop weight-loss drugs for animals, as pet owners grapple with health risks versus their pets' cute appearances.
Explosive Price Increases from US Pharmaceutical Companies
US pharmaceutical companies are seeing substantial price hikes affecting consumers and healthcare costs.
In 2025, European tech firms thrived on the stock exchange; the Danish king of pharmaceutical companies struggled
In 2025, while American tech giants excelled in the AI competition, the European market showcased a diverse range of high-cap companies, with significant variances in stock performance, particularly struggling for Novo Nordisk.